FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Domenic Sica

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Drug Therapy, Combination

Anatomy

Co-author Network

Publications

TOP 3
Richard A Preston; Zhen Zhao; Caroline Dudkowski; Dyal Garg; Aziz Karim; Oliver Lenz; Domenic A Sica
Single-Center Evaluation of the Single-Dose Pharmacokinetics of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Renal Impairment.
Faiez Zannad; George L Bakris; Johann Bauersachs; Farzin Beygui; Alain Cohen-Solal; Gerasimos S Filippatos; Wendy Gattis-Stough; Mihai Gheorghiade; Aldo P Maggioni; Ziad A Massy; John J V McMurray; Robert J Mentz; Christopher M O'Connor; Atul Pathak; Ileana L Piña; Patrick Rossignol; Luis M Ruilope; Hani N Sabbah; Domenic A Sica; Allan D Struthers; Karl Swedberg; Luigi Tavazzi; Adriaan A Voors; Bertram Pitt
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice.
Gordon M Burke; Domenic A Sica; William H Frishman
Renal sympathetic denervation for the treatment of systemic hypertension.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Domenic Sica (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Richard A Preston; Zhen Zhao; Caroline Dudkowski; Dyal Garg; Aziz Karim; Oliver Lenz; Domenic A Sica
Single-Center Evaluation of the Single-Dose Pharmacokinetics of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Renal Impairment.
Clinical pharmacokinetics 2013;52(5):347-58.
2012: Faiez Zannad; George L Bakris; Johann Bauersachs; Farzin Beygui; Alain Cohen-Solal; Gerasimos S Filippatos; Wendy Gattis-Stough; Mihai Gheorghiade; Aldo P Maggioni; Ziad A Massy; John J V McMurray; Robert J Mentz; Christopher M O'Connor; Atul Pathak; Ileana L Piña; Patrick Rossignol; Luis M Ruilope; Hani N Sabbah; Domenic A Sica; Allan D Struthers; Karl Swedberg; Luigi Tavazzi; Adriaan A Voors; Bertram Pitt
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice.
European heart journal 2012;33(22):2782-95.
2012: Gordon M Burke; Domenic A Sica; William H Frishman
Renal sympathetic denervation for the treatment of systemic hypertension.
Cardiology in review 2012;20(6):274-8.
2012: Keyur B Shah; Kyle J Gunnerson; Michael L Hess; Vigneshwar Kasirajan; Daniel G Tang; Domenic A Sica
Impact of low-dose B-type natriuretic peptide infusion on urine output after total artificial heart implantation.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2012;31(6):670-2.
2012: Domenic A Sica
Diuretic use in renal disease.
Nature reviews. Nephrology 2012;8(2):100-9.
2011: Domenic A Sica
What is the role of aldosterone excess in resistant hypertension and how should it be investigated and treated?
Current cardiology reports 2011;13(6):520-6.
2011: Gary R Matzke; Ravindra Mehta; Bruce A Mueller; Deborah A Pasko; Franz Schaefer; Domenic A Sica; Jason G Umans; George R Aronoff; Arthur J Atkinson; William M Bennett; Brian S Decker; Kai-Uwe Eckardt; Thomas Golper; Darren W Grabe; Lesley A Inker; Bertram Kasiske; Frieder Keller; Jan T Kielstein; Patrick Murray
Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
Kidney international 2011;80(11):1122-37.
2011: Rahim Kassamali; Domenic A Sica
Acetazolamide: a forgotten diuretic agent.
Cardiology in review 2011;19(6):276-8.
2011: Thomas Unger; Ludovit Paulis; Domenic A Sica
Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.
European heart journal 2011;32(22):2739-47.
2011: Domenic A Sica; Barry Carter; William Cushman; Lee Hamm
Thiazide and loop diuretics.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(9):639-43.
2011: John D Bisognano; Peter W de Leeuw; Abraham A Kroon; Mitra K Nadim; Luis Sanchez; Jill Schafer; George Bakris; Domenic A Sica
Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.
Journal of the American College of Cardiology 2011;58(7):765-73.
2011: John M Flack; Domenic A Sica; Shawna Nesbitt
Chlorthalidone versus hydrochlorothiazide as the preferred diuretic: is there a verdict yet?
Hypertension 2011;57(4):665-6.
2011: Maria M Ng; Domenic A Sica; William H Frishman
Rheos: an implantable carotid sinus stimulation device for the nonpharmacologic treatment of resistant hypertension.
Cardiology in review 2011;19(2):52-7.
2011: Domenic A Sica
Device-guided breathing and hypertension: a yet to be determined positioning.
Cardiology in review 2011;19(2):45-6.
2011: Raymond R Townsend; Domenic A Sica
Beyond conventional considerations: newer devices used in blood pressure measurement and management.
Advances in chronic kidney disease 2011;18(1):48-54.
2011: Domenic A Sica
Pharmacologic Issues in treating hypertension in CKD.
Advances in chronic kidney disease 2011;18(1):42-7.
2011: Raymond R Townsend; Domenic A Sica
On the waterfront.
Advances in chronic kidney disease 2011;18(1):3-5.
2011: Domenic A Sica; John M Flack
Treatment considerations with aldosterone receptor antagonists.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(1):65-9.
2010: John M Flack; Domenic A Sica; George Bakris; Angela L Brown; Keith C Ferdinand; Richard H Grimm; W Dallas Hall; Wendell E Jones; David S Kountz; Janice P Lea; Samar Nasser; Shawna D Nesbitt; Elijah Saunders; Margaret Scisney-Matlock; Kenneth A Jamerson
Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement.
Hypertension 2010;56(5):780-800.
2010: Siddhartha S Ghosh; Fadi Salloum; Antonio Abbate; Richard Krieg; Domenic A Sica; Todd W Gehr; Rakesh C Kukreja
Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats.
American journal of physiology. Heart and circulatory physiology 2010;299(4):H975-84.
2010: Domenic A Sica
Angiotensin receptor blockers and the risk of malignancy: a note of caution.
Drug safety : an international journal of medical toxicology and drug experience 2010;33(9):709-12.
2010: Domenic A Sica
Drug combinations in the treatment of hypertension: never-ending novelty.
Hypertension 2010;56(1):22-3.
2010: Domenic A Sica
The evolution of renin-angiotensin blockade: angiotensin-converting enzyme inhibitors as the starting point.
Current hypertension reports 2010;12(2):67-73.
2009: Domenic A Sica
Can focused US with a diagnostic US contrast agent favorably affect renal function?
Radiology 2009;253(3):577-8.
2009: Youhua Zhang; Zoran B Popovic; Steve Bibevski; Itaf Fakhry; Domenic A Sica; David Van Wagoner; Todor N Mazgalev
Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.
Circulation. Heart failure 2009;2(6):692-9.
2009: William C Roberts; George L Bakris; Henry R Black; Domenic A Sica; Destry J Sulkes
The editor's roundtable: prehypertension.
The American journal of cardiology 2009;104(8):1105-15.
2009: Domenic A Sica
Fibrate therapy and renal function.
Current atherosclerosis reports 2009;11(5):338-42.
2009: Domenic A Sica
Chlorthalidone - a renaissance in use?
Expert opinion on pharmacotherapy 2009;10(13):2037-9.
2009: Masahiko Nagahama; Domenic A Sica
Pamidronate-induced kidney injury in a patient with metastatic breast cancer.
The American journal of the medical sciences 2009;338(3):225-8.
2009: Domenic A Sica
Hyperkalemia risk in chronic kidney disease: deterrent to the use of aldosterone receptor antagonism or not.
Hypertension 2009;53(5):749-50.
2009: Nicolas W Shammas; Domenic A Sica; Peter P. Toth
A guide to the management of blood pressure in the diabetic hypertensive patient.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2009;9(3):149-62.
2008: Dion H Zappe; James R Sowers; Willa A Hsueh; Steven M Haffner; Prakash C Deedwania; Vivian A Fonseca; Lucy Keeling; Domenic A Sica
Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(12):894-903.
2008: Domenic A Sica
Direct renin inhibition--commonly asked questions.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(11):871-5.
2008: Domenic A Sica
Do pleiotropic effects of antihypertensive medications exist or is it all about the blood pressure?
Current hypertension reports 2008;10(5):415-20.
2008: Domenic A Sica
Edema mechanisms in the patient with heart failure and treatment options.
Heart failure clinics 2008;4(4):511-8.
2008: Domenic A Sica
Management of hypertension in the outpatient setting.
Primary care 2008;35(3):451-73, vi.
2008: Domenic A Sica
Endothelin receptor antagonism: what does the future hold?
Hypertension 2008;52(3):460-1.
2008: Domenic A Sica; Henry R Black
Pharmacologic considerations in the positioning of beta-blockers in antihypertensive therapy.
Current hypertension reports 2008;10(4):330-5.
2008: Domenic A Sica
The kidney and hypertension: causes and treatment.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(7):541-8.
2008: Domenic A Sica
Endocrine causes of secondary hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(7):534-40.
2007: Joel M Neutel; Domenic A Sica; Stanley S Franklin
Hypertension control: still not there-how to select the right add-on therapy to reach goal blood pressures.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(11):889-96.
2007: Don Farthing; Lynne Gehr; H Thomas Karnes; Domenic A Sica; Todd W B Gehr; Terri Larus; Christine Farthing; Lei Xi
Effects of salicylic acid on post-ischaemic ventricular function and purine efflux in isolated mouse hearts.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2007;12(6):623-34.
2007: Domenic A Sica; Todd W B Gehr; William H Frishman
Use of diuretics in the treatment of heart failure in the elderly.
Heart failure clinics 2007;3(4):455-64.
2007: Barry L Carter; Domenic A Sica
Strategies to improve the cardiovascular risk profile of thiazide-type diuretics as used in the management of hypertension.
Expert opinion on drug safety 2007;6(5):583-94.
2007: Dan Carl; Domenic A Sica
Acute phosphate nephropathy following colonoscopy preparation.
The American journal of the medical sciences 2007;334(3):151-4.
2007: Domenic A Sica; Rosemarie Mannino
Antihypertensive medications and anemia.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(9):723-7.
2007: Marvin Moser; Joseph L Izzo; Domenic A Sica
The use of renin inhibitors in the management of hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(9):701-5.
2007: Domenic A Sica; Dan Carl; Alvin Zfass
Acute phosphate nephropathy--an emerging issue.
The American journal of gastroenterology 2007;102(9):1844-7.
2007: Reza Sepehrdad; William H Frishman; Charles T Stier; Domenic A Sica
Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.
Cardiology in review 2007;15(5):242-56.
2007: Dan Carl; Domenic A Sica
Obstructive sleep apnea, hypertension, and wakefulness-promoting agents.
Current hypertension reports 2007;9(4):329-31.
2007: Dan Carl; Domenic A Sica
Spironolactone use in resistant hypertension.
Current hypertension reports 2007;9(4):297-8.
2007: Domenic A Sica
Hypertension treatment: how important is consistency of effect?
Hypertension 2007;50(2):287-8.
2007: Domenic A Sica
Loop diuretic therapy, thiamine balance, and heart failure.
Congestive heart failure (Greenwich, Conn.) 2007;13(4):244-7.
2007: Don Farthing; Domenic A Sica; Todd W B Gehr; Bill Wilson; Itaf Fakhry; Terri Larus; Christine Farthing; H Thomas Karnes
An HPLC method for determination of inosine and hypoxanthine in human plasma from healthy volunteers and patients presenting with potential acute cardiac ischemia.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2007;854(1-2):158-64.
2007: Domenic A Sica
Centrally acting antihypertensive agents: an update.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(5):399-405.
2007: James M McKenney; Domenic A Sica
Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
Pharmacotherapy 2007;27(5):715-28.
2007: James M McKenney; Domenic A Sica
Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2007;64(6):595-605.
2007: Domenic A Sica; Todd W B Gehr; William H Frishman
Use of diuretics in the treatment of heart failure in the elderly.
Clinics in geriatric medicine 2007;23(1):107-21.
2007: Domenic A Sica
Calcium channel blockers: monotherapy and dual therapy considerations in the treatment of hypertension.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2007;7 Suppl 1():1-3.
2007: Domenic A Sica
The risks and benefits of therapy with aldosterone receptor antagonist therapy.
Current drug safety 2007;2(1):71-7.
2007: Donald F Brophy; Domenic A Sica
Use of enoxaparin in patients with chronic kidney disease: safety considerations.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(11):991-4.
2007: Rebecca S Grubbs; Domenic A Sica
Taking the pressure off type 2 diabetes mellitus: implementing hypertension guidelines.
Progress in cardiovascular nursing 2007;22(3):159-65.
2007: Domenic A Sica
Considerations in drug handling in renal disease.
Clinical pharmacokinetics 2007;46(8):677-9.
2007: Maureen P Flattery; Domenic A Sica
Angiotensin-converting enzyme inhibitor-related angioedema: recognition and treatment.
Progress in cardiovascular nursing 2007;22(1):47-51.
2007: Domenic A Sica
Combination ACE inhibitor and angiotensin receptor blocker therapy - future considerations.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(1):78-86.
2006: Domenic A Sica; Atsuhiro Ichihara
The Renin Report.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2006;7(4):247-51.
2006: Michael A Weber; George L Bakris; Elizabeth A Tarka; Malini Iyengar; Richard Fleck; Domenic A Sica
Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(12):840-9.
2006: Michael A Weber; Domenic A Sica; Elizabeth A Tarka; Malini Iyengar; Richard Fleck; George L Bakris
Controlled-release carvedilol in the treatment of essential hypertension.
The American journal of cardiology 2006;98(7A):32L-38L.
2006: Domenic A Sica
Design of a novel controlled-release formulation of carvedilol: pharmacology and clinical aspects. Introduction.
The American journal of cardiology 2006;98(7A):1L-4L.
2006: Domenic A Sica; Thomas E Lohmeier
Baroreflex activation for the treatment of hypertension: principles and practice.
Expert review of medical devices 2006;3(5):595-601.
2006: Don Farthing; Lei Xi; Lynne Gehr; Domenic A Sica; Terri Larus; H Thomas Karnes
High-performance liquid chromatography (HPLC) determination of inosine, a potential biomarker for initial cardiac ischaemia, using isolated mouse hearts.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2006;11(5):449-59.
2006: Domenic A Sica
The Valsartan Antihypertensive Long-Term Use Evaluation trial: a study in contrasts.
Hypertension 2006;48(3):362-3.
2006: Dan Carl; Domenic A Sica
Angiotensin-receptor blockers for prehypertension.
Current hypertension reports 2006;8(4):307-8.
2006: Domenic A Sica
Drospirenone: an antihypertensive in waiting.
Hypertension 2006;48(2):205-6.
2006: Domenic A Sica; Lisa Brath
Angiotensin-converting enzyme inhibition-emerging pulmonary issues relating to cough.
Congestive heart failure (Greenwich, Conn.) 2006;12(4):223-6.
2006: Domenic A Sica
Spironolactone: an old friend rediscovered.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(7):467-9.
2006: Domenic A Sica
Interaction of grapefruit juice and calcium channel blockers.
American journal of hypertension 2006;19(7):768-73.
2006: Domenic A Sica
Sodium and water retention in heart failure and diuretic therapy: basic mechanisms.
Cleveland Clinic journal of medicine 2006;73 Suppl 2():S2-7; discussion S30-3.
2006: Domenic A Sica
Angiotensin receptor blockers: new considerations in their mechanism of action.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(5):381-5.
2006: Domenic A Sica
Angiogenesis inhibitors and hypertension: an emerging issue.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1329-31.
2006: Domenic A Sica
BiDil (isosorbide dinitrate and hydralazine hydrochloride).
Congestive heart failure (Greenwich, Conn.) 2006;12(2):110-1.
2006: Domenic A Sica
Ultrafiltration for acute decompensated heart failure: has its time come?
Expert review of medical devices 2006;3(2):131-3.
2006: Domenic A Sica
Chlorthalidone: has it always been the best thiazide-type diuretic?
Hypertension 2006;47(3):321-2.
2006: Domenic A Sica; Todd W B Gehr
Desmopressin : safety considerations in patients with chronic renal disease.
Drug safety : an international journal of medical toxicology and drug experience 2006;29(7):553-6.
2006: Domenic A Sica
Hyponatremia and heart failure--treatment considerations.
Congestive heart failure (Greenwich, Conn.) 2006;12(1):55-60.
2006: Domenic A Sica
Antihypertensive therapy and its effects on potassium homeostasis.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(1):67-73.
2006: Domenic A Sica
Pharmacotherapy review: calcium channel blockers.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(1):53-6.
2005: Domenic A Sica
Alpha1-adrenergic blockers: current usage considerations.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(12):757-62.
2005: Don Farthing; Domenic A Sica; Itaf Fakhry; Terri Larus; Sid Ghosh; Christine Farthing; Michael Vranian; Todd W B Gehr
Simple HPLC-UV method for determination of iohexol, iothalamate, p-aminohippuric acid and n-acetyl-p-aminohippuric acid in human plasma and urine with ERPF, GFR and ERPF/GFR ratio determination using colorimetric analysis.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;826(1-2):267-72.
2005: Domenic A Sica
Pharmacotherapy review: Angiotensin receptor antagonists.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(11):681-4.
2005: Domenic A Sica
Hyponatremia and heart failure--pathophysiology and implications.
Congestive heart failure (Greenwich, Conn.) 2005;11(5):274-7.
2005: Domenic A Sica; Rebecca Grubbs
Transdermal clonidine: therapeutic considerations.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(9):558-62.
2005: Domenic A Sica; Thomas D Giles; Henry R Black; Vito M Campese
ACE inhibitors: over two decades of use.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(9):531-7.
2005: Domenic A Sica
Angiotensin-converting enzyme inhibitor use in the year 2005.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(8 Suppl 2):8-11.
2005: Domenic A Sica
Pharmacotherapy review: angiotensin-converting enzyme inhibitors.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(8):485-8.
2005: Domenic A Sica
Clinical trials report. White-coat hypertension and stroke incidence.
Current hypertension reports 2005;7(4):273-4.
2005: Domenic A Sica
The risks and benefits of aldosterone antagonists.
Current heart failure reports 2005;2(2):65-71.
2005: Domenic A Sica; Dan Carl
Pathologic basis and treatment considerations in chronic kidney disease-related hypertension.
Seminars in nephrology 2005;25(4):246-51.
2005: William R Ravis; Susan Reid; Domenic A Sica; Dwain S Tolbert
Pharmacokinetics of eplerenone after single and multiple dosing in subjects with and without renal impairment.
Journal of clinical pharmacology 2005;45(7):810-21.
2005: Domenic A Sica; Mark Wood; Michael Hess
Gender and its effect in cardiovascular pharmacotherapeutics: recent considerations.
Congestive heart failure (Greenwich, Conn.) 2005;11(3):163-6.
2005: Domenic A Sica
Over-the-counter statin therapy--pros and cons.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(5):262, 299.
2005: Samy I McFarlane; Domenic A Sica; James R Sowers
Stroke in patients with diabetes and hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(5):286-92; quiz 293-4.
2005: Michael Ganz; Rasoul Mokabberi; Domenic A Sica
Comparison of blood pressure control with amlodipine and controlled-release isradipine: an open-label, drug substitution study.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(4 Suppl 1):27-31.
2005: Domenic A Sica
Calcium channel blocker class heterogeneity: select aspects of pharmacokinetics and pharmacodynamics.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(4 Suppl 1):21-6.
2005: John M Flack; Domenic A Sica
Therapeutic considerations in the African-American patient with hypertension: considerations with calcium channel blocker therapy.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(4 Suppl 1):9-14.
2005: Domenic A Sica
Calcium channel blockers: a more expansive treatment role.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(4 Suppl 1):2-4.
2005: Domenic A Sica
New considerations relating to class effect with angiotensin-converting enzyme inhibitors--the PEACE study.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(3):188-93.
2005: Domenic A Sica
Diuretics should continue to be one of the preferred initial therapies in the management of hypertension: the argument against.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(2):117-20; quiz 121-2.
2005: Domenic A Sica; Todd W B Gehr; Siddhartha Ghosh
Clinical pharmacokinetics of losartan.
Clinical pharmacokinetics 2005;44(8):797-814.
2005: Domenic A Sica
Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis.
Heart failure reviews 2005;10(1):23-9.
2005: Domenic A Sica
Angiotensin receptor blockers and drug-drug interactions.
Expert opinion on drug safety 2005;4(1):139-40.
2005: Domenic A Sica
Current concepts of pharmacotherapy in hypertension. Carvedilol: new considerations for its use in the diabetic patient with hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(1):59-64.
2004: Domenic A Sica
Current concepts of pharmacotherapy in hypertension: thiazide-type diuretics: ongoing considerations on mechanism of action.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(11):661-4.
2004: Domenic A Sica
Hypertension, renal disease, and drug considerations.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(10 Suppl 2):24-30.
2004: Domenic A Sica; Michael Hess
Pharmacotherapy in congestive heart failure: aldosterone receptor antagonism: interface with hyperkalemia in heart failure.
Congestive heart failure (Greenwich, Conn.) 2004;10(5):259-64.
2004: Domenic A Sica
Diuretic-related side effects: development and treatment.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(9):532-40.
2004: Jackson T Wright; Domenic A Sica; Theophilus J Gana; Kathryn Bohannon; Luz G Pascual; Kenneth S Albert
Antihypertensive efficacy of night-time graded-release diltiazem versus morning amlodipine in African Americans.
American journal of hypertension 2004;17(9):734-42.
2004: Marvin Moser; Vasilios Papademetriou; Thomas G Pickering; Domenic A Sica
Hypertension treatment guidelines.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(8):452-7.
2004: Niall McLaughlin; Todd W B Gehr; Domenic A Sica
Aldosterone-receptor antagonism and end-stage renal disease.
Current hypertension reports 2004;6(4):327-30.
2004: Dawn K Wilson; Wendy Kliewer; Domenic A Sica
The relationship between exposure to violence and blood pressure mechanisms.
Current hypertension reports 2004;6(4):321-6.
2004: Nosratola D Vaziri; Domenic A Sica
Lead-induced hypertension: role of oxidative stress.
Current hypertension reports 2004;6(4):314-20.
2004: Michael A Weber; Domenic A Sica
Clinical trials report. Consequences of new-onset diabetes during the treatment of hypertension.
Current hypertension reports 2004;6(4):291-2.
2004: Domenic A Sica
Angiotensin-converting enzyme inhibitors side effects--physiologic and non-physiologic considerations.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(7):410-6.
2004: Thomas H Hostetter; Elisa H Gladstone; Domenic A Sica
National Kidney Disease Education Program in 2004: a program in evolution.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(6):299-302.
2004: Domenic A Sica
ACE inhibitor intolerance and lessons learned from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) trials.
Congestive heart failure (Greenwich, Conn.) 2004;10(3):160-4.
2004: Domenic A Sica
Minoxidil: an underused vasodilator for resistant or severe hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(5):283-7.
2004: Domenic A Sica; Joel M Neutel; Michael A Weber; Neil Manowitz
The antihypertensive efficacy and safety of a chronotherapeutic formulation of propranolol in patients with hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(5):231-41.
2004: Don Farthing; Terri Larus; Itaf Fakhry; Todd W B Gehr; Jayne Prats; Domenic A Sica
Liquid chromatography method for determination of bivalirudin in human plasma and urine using automated ortho-phthalaldehyde derivatization and fluorescence detection.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;802(2):355-9.
2004: Domenic A Sica
Fixed-dose combination therapy--is it time for this approach to hypertension and dyslipidemia management?
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(4):164-7.
2004: Clyde W Yancy; Domenic A Sica
Cardiovascular disease in African Americans.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(4 Suppl 1):54-6.
2004: Domenic A Sica
Hypertension and end-organ disease in African Americans: case presentations.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(4 Suppl 1):48-53.
2004: Domenic A Sica
EUROPA: has anything new been learned with angiotensin-converting enzyme inhibitors?
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(2):91-5.
2004: Domenic A Sica
Calcium channel blockers and the kidney.
Clinical cornerstone 2004;6(4):39-52.
2004: Domenic A Sica
Optimizing hypertension and vascular health: focus on ethnicity.
Clinical cornerstone 2004;6(4):28-38.
2003: Domenic A Sica
Combination angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy: its role in clinical practice.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(6):414-20.
2003: Marvin Moser; Jan Basile; Domenic A Sica
Roundtable discussion: Electrolytes in cardiovascular disease and hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(6):402-7.
2003: Domenic A Sica
Pharmacotherapy in congestive heart failure: drug absorption in the management of congestive heart failure: loop diuretics.
Congestive heart failure (Greenwich, Conn.) 2003;9(5):287-92.
2003: Domenic A Sica
JNC 7: has the definition of hypertension changed?
Heart disease (Hagerstown, Md.) 2003;5(5):305-7.
2003: Domenic A Sica; Todd W B Gehr
Diuretic use in stage 5 chronic kidney disease and end-stage renal disease.
Current opinion in nephrology and hypertension 2003;12(5):483-90.
2003: Domenic A Sica
Renal handling of angiotensin receptor blockers: clinical relevance.
Current hypertension reports 2003;5(4):337-9.
2003: Michael A Weber; Domenic A Sica
A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly.
Current hypertension reports 2003;5(4):319-21.
2003: Domenic A Sica; Todd W B Gehr; Clyde Yancy
Hyperkalemia, congestive heart failure, and aldosterone receptor antagonism.
Congestive heart failure (Greenwich, Conn.) 2003;9(4):224-9.
2003: Siddhartha S Ghosh; Todd W B Gehr; Shobha Ghosh; Itaf Fakhry; Domenic A Sica; Vijay Lyall; Anton C Schoolwerth
PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase.
Kidney international 2003;64(1):52-62.
2003: Harvey J Sugerman; Luke G Wolfe; Domenic A Sica; John N Clore
Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss.
Annals of surgery 2003;237(6):751-6; discussion 757-8.
2003: Domenic A Sica
Is there HOPE for ALLHat: similarities and differences.
Expert review of cardiovascular therapy 2003;1(1):1-2.
2003: Domenic A Sica
Are current strategies for treating hypertension effective?
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(3 Suppl 2):23-32.
2003: Domenic A Sica; William H Frishman; Neil Manowitz
Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
Heart disease (Hagerstown, Md.) 2003;5(3):176-81.
2003: Domenic A Sica
ALLHAT: is the final answer in?
Heart disease (Hagerstown, Md.) 2003;5(3):171-5.
2003: Janice G Douglas; George L Bakris; Murray Epstein; Keith C Ferdinand; Carlos Ferrario; John M Flack; Kenneth A Jamerson; Wendell E Jones; Julian Haywood; Randall Maxey; Elizabeth Ofili; Elijah Saunders; Ernesto L Schiffrin; Domenic A Sica; James R Sowers; Donald G Vidt
Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.
Archives of internal medicine 2003;163(5):525-41.
2003: Domenic A Sica
Aldosterone receptor blockade: a therapy resurrected.
Heart disease (Hagerstown, Md.) 2003;5(2):85-8.
2003: Domenic A Sica
Metolazone and its role in edema management.
Congestive heart failure (Greenwich, Conn.) 2003;9(2):100-5.
2003: Domenic A Sica
The African American Study of Kidney Disease and Hypertension (AASK) trial: what more have we learned?
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(2):159-67.
2003: Domenic A Sica; Todd W B Gehr
Calcium-channel blockers and end-stage renal disease: pharmacokinetic and pharmacodynamic considerations.
Current opinion in nephrology and hypertension 2003;12(2):123-31.
2002: Domenic A Sica; Todd W B Gehr
The pharmacokinetics and pharmacodynamics of angiotensin-receptor blockers in end-stage renal disease.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2002;3(4):247-54.
2002: Siddhartha Ghosh; Domenic A Sica; Anton C Schoolwerth; Richard J Quigg; Mark Haas; Itaf Fakhry; Todd W B Gehr
The role of the renin-angiotensin system in cholesterol and puromycin mediated renal injury.
The American journal of the medical sciences 2002;324(6):296-304.
2002: Thomas Yeh; Andrew S Wechsler; Laura Graham; Kathryn E Loesser; Domenic A Sica; Luke Wolfe; Emma R Jakoi
Central sympathetic blockade ameliorates brain death-induced cardiotoxicity and associated changes in myocardial gene expression.
The Journal of thoracic and cardiovascular surgery 2002;124(6):1087-98.
2002: Domenic A Sica; Henry R Black
Angioedema in heart failure: occurrence with ACE inhibitors and safety of angiotensin receptor blocker therapy.
Congestive heart failure (Greenwich, Conn.) 2002;8(6):334-41, 345.
2002: Domenic A Sica
Eplerenone: a new aldosterone receptor antagonist--are the FDAs restrictions appropriate?
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(6):441-5.
2002: Dawn K Wilson; Wendy Kliewer; Nicole Teasley; Laura Plybon; Domenic A Sica
Violence exposure, catecholamine excretion, and blood pressure nondipping status in African American male versus female adolescents.
Psychosomatic medicine 2002;64(6):906-15.
2002: William B White; Domenic A Sica; David Calhoun; George A Mansoor; Robert J Anders
Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
American heart journal 2002;144(4):657-65.
2002: Domenic A Sica; Henry R Black
Current concepts of pharmacotherapy in hypertension: ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used?
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(5):375-80.
2002: Domenic A Sica; Anton C Schoolwerth
Part 1. Uric acid and losartan.
Current opinion in nephrology and hypertension 2002;11(5):475-82.
2002: Domenic A Sica
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Current hypertension reports 2002;4(4):321-3.
2002: Domenic A Sica; Michael Weber
The Losartan Intervention for Endpoint Reduction (LIFE) trial-have angiotensin-receptor blockers come of age?
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(4):301-5.
2002: Domenic A Sica
The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2002;3(2):66-71.
2002: Domenic A Sica
Rationale for combination therapy in the treatment of hypertension.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2002;3(2):63-5.
2002: Domenic A Sica
Doxazosin and congestive heart failure.
Congestive heart failure (Greenwich, Conn.) 2002;8(3):178-84.
2002: Domenic A Sica
Premature termination of clinical trials--lessons learned.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(3):219-25.
2002: Domenic A Sica; A D Struthers; William Cushman; M Wood; J S Banas; M Epstein
Importance of potassium in cardiovascular disease.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(3):198-206.
2002: Domenic A Sica
The implications of renal impairment among patients undergoing percutaneous coronary intervention.
The Journal of invasive cardiology 2002;14 Suppl B():30B-37B.
2002: Domenic A Sica
ACE inhibitors and stroke: new considerations.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(2):126-9, 133.
2002: Domenic A Sica; Todd W B Gehr
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and rhabdomyolysis: considerations in the renal failure patient.
Current opinion in nephrology and hypertension 2002;11(2):123-33.
2002: Randall E Merchant; Cynthia A Andre; Domenic A Sica
Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension.
Journal of medicinal food 2002;5(3):141-52.
2002: Dawn K Wilson; Ronald Friend; Nicole Teasley; Sabra Green; Irvine Lee Reaves; Domenic A Sica
Motivational versus social cognitive interventions for promoting fruit and vegetable intake and physical activity in African American adolescents.
Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 2002;24(4):310-9.
2002: Domenic A Sica
Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.
Drugs 2002;62(3):443-62.
2002: Domenic A Sica; George L Bakris
Type 2 diabetes: RENAAL and IDNT--the emergence of new treatment options.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(1):52-7.
2002: Domenic A Sica; Todd W B Gehr
Rhabdomyolysis and statin therapy: relevance to the elderly.
The American journal of geriatric cardiology 2002;11(1):48-55.
2001: William B White; YA Anwar; George A Mansoor; Domenic A Sica
Evaluation of the 24-hour blood pressure effects of eprosartan in patients with systemic hypertension.
American journal of hypertension 2001;14(12):1248-55.
2001: Domenic A Sica; W J Elliott
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in combination: theory and practice.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(6):383-7.
2001: Domenic A Sica
Dosage considerations with perindopril for systemic hypertension.
The American journal of cardiology 2001;88(7A):13i-18i.
2001: Domenic A Sica
Current concepts of pharmacotherapy in hypertension: combination calcium channel blocker therapy in the treatment of hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(5):322-7.
2001: Domenic A Sica
Lessons learned from prematurely terminated clinical trials.
Current hypertension reports 2001;3(4):360-6.
2001: Domenic A Sica; J G Douglas
The African American Study of Kidney Disease and Hypertension (AASK): new findings.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(4):244-51.
2001: Domenic A Sica
Pharmacology and clinical efficacy of angiotensin receptor blockers.
American journal of hypertension 2001;14(7 Pt 2):242S-247S.
2001: Domenic A Sica
Current concepts of pharmacotherapy in hypertension--ophthalmically administered beta blockers and their cardiopulmonary effects.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(3):175-8.
2001: Domenic A Sica; Todd W B Gehr
Direct vasodilators and their role in hypertension management: minoxidil.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(2):110-4.
2001: Domenic A Sica
Clinical pharmacology of the angiotensin receptor antagonists.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(1):45-9.
2000: Domenic A Sica; W Liao; Todd W B Gehr; S Khan; Mohammed Jemal; CL Delaney; I M Ferreira; B K Malhotra
Disposition and safety of omapatrilat in subjects with renal impairment.
Clinical pharmacology and therapeutics 2000;68(3):261-9.
2000: GL Bloomfield; Harvey J Sugerman; Charles R Blocher; Todd W B Gehr; Domenic A Sica
Chronically increased intra-abdominal pressure produces systemic hypertension in dogs.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(7):819-24.
2000: Domenic A Sica; C E Halstenson; Todd W B Gehr; W F Keane
Pharmacokinetics and blood pressure response of losartan in end-stage renal disease.
Clinical pharmacokinetics 2000;38(6):519-26.
2000: Domenic A Sica; Todd W B Gehr; A Fernandez
Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.
Drug safety : an international journal of medical toxicology and drug experience 2000;22(5):350-60.
2000: James M Doty; Bob H Saggi; Charles R Blocher; Itaf Fakhry; Todd W B Gehr; Domenic A Sica; Harvey J Sugerman
Effects of increased renal parenchymal pressure on renal function.
The Journal of trauma 2000;48(5):874-7.
2000: A A Pedro; Todd W B Gehr; Donald F Brophy; Domenic A Sica
The pharmacokinetics and pharmacodynamics of losartan in continuous ambulatory peritoneal dialysis.
Journal of clinical pharmacology 2000;40(4):389-95.
2000: Elizabeth Bd Ripley; K King; Domenic A Sica
Racial differences in response to acute dosing with hydrochlorothiazide.
American journal of hypertension 2000;13(2):157-64.
2000: Domenic A Sica
The importance of the sympathetic nervous system and systolic hypertension in patients with hypertension: benefits in treating patients with increased cardiovascular risk.
Blood pressure monitoring 2000;5 Suppl 2():S19-25.
2000: William B White; Domenic A Sica
Vascular disease and the renin-angiotensin system in the patient with hypertension.
Blood pressure monitoring 2000;5 Suppl 2():S1.
2000: Dawn K Wilson; Wendy Kliewer; L Plybon; Domenic A Sica
Socioeconomic status and blood pressure reactivity in healthy black adolescents.
Hypertension 2000;35(1 Pt 2):496-500.
1999: James M Doty; Bob H Saggi; Harvey J Sugerman; Charles R Blocher; R Pin; Itaf Fakhry; Todd W B Gehr; Domenic A Sica
Effect of increased renal venous pressure on renal function.
The Journal of trauma 1999;47(6):1000-3.
1999: Domenic A Sica
Old antihypertensive agents-diuretics and beta-blockers: do we know how and in whom they lower blood pressure?
Current hypertension reports 1999;1(4):296-304.
1999: Dawn K Wilson; Domenic A Sica; S B Miller
Effects of potassium on blood pressure in salt-sensitive and salt-resistant black adolescents.
Hypertension 1999;34(2):181-6.
1999: Todd W B Gehr; David M Tenero; Duane A Boyle; Y Qian; Domenic A Sica; N H Shusterman
The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency.
European journal of clinical pharmacology 1999;55(4):269-77.
1999: Don Farthing; Domenic A Sica; C Abernathy; Itaf Fakhry; J D Roberts; D J Abraham; Paul Steven Swerdlow
High-performance liquid chromatographic method for determination of vanillin and vanillic acid in human plasma, red blood cells and urine.
Journal of chromatography. B, Biomedical sciences and applications 1999;726(1-2):303-7.
1999: Domenic A Sica
Review of eprosartan: a new angiotensin II receptor antagonist. Summary.
Pharmacotherapy 1999;19(4 Pt 2):108S-109S.
1999: Domenic A Sica; N K Hollenberg
The renal profile of eprosartan.
Pharmacotherapy 1999;19(4 Pt 2):86S-94S.
1999: Dawn K Wilson; Domenic A Sica; S B Miller
Ambulatory blood pressure nondipping status in salt-sensitive and salt-resistant black adolescents.
American journal of hypertension 1999;12(2 Pt 1):159-65.
1999: Thomas Yeh; Andrew S Wechsler; Laura J Graham; Kathryn E Loesser; Domenic A Sica; L Wolfe; Emma R Jakoi
Acute brain death alters left ventricular myocardial gene expression.
The Journal of thoracic and cardiovascular surgery 1999;117(2):365-74.
1999: Domenic A Sica
What are the influences of salt, potassium, the sympathetic nervous system, and the renin-angiotensin system on the circadian variation in blood pressure?
Blood pressure monitoring 1999;4 Suppl 2():S9-S16.
1999: Dawn K Wilson; Wendy Kliewer; L Bayer; D Jones; A Welleford; M Heiney; Domenic A Sica
The influence of gender and emotional versus instrumental support on cardiovascular reactivity in African-American adolescents.
Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 1999;21(3):235-43.
1999: Dawn K Wilson; L Bayer; J S Krishnamoorthy; G Ampey-Thornhill; S C Nicholson; Domenic A Sica
The prevalence of salt sensitivity in an African-American adolescent population.
Ethnicity & disease 1999;9(3):350-8.
1999: Domenic A Sica
Drug absorption in congestive heart failure: impact on management.
Progress in cardiovascular nursing 1999;14(2):72-4.
1999: Domenic A Sica
Drug absorption in congestive heart failure: impact on management.
Progress in cardiovascular nursing 1999;14(1):30-2.
1998: Don Farthing; Itaf Fakhry; Elizabeth Bd Ripley; Domenic A Sica
Simple method for determination of hydrochlorothiazide in human urine by high performance liquid chromatography utilizing narrowbore chromatography.
Journal of pharmaceutical and biomedical analysis 1998;17(8):1455-9.
1998: V P Calabrese; K A Lloyd; P Brancazio; E Cefali; P Martin; J Wall; Domenic A Sica
N-0923, a novel soluble dopamine D2 agonist in the treatment of parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 1998;13(5):768-74.
1997: Don Farthing; Domenic A Sica; Itaf Fakhry; A Pedro; Todd W B Gehr
Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate.
Journal of chromatography. B, Biomedical sciences and applications 1997;704(1-2):374-8.
1997: Domenic A Sica; Maria R Marino; Janis L Hammett; I Ferreira; Todd W B Gehr; Neville F Ford
The pharmacokinetics of irbesartan in renal failure and maintenance hemodialysis.
Clinical pharmacology and therapeutics 1997;62(6):610-8.
1997: GL Bloomfield; Charles R Blocher; Itaf Fakhry; Domenic A Sica; Harvey J Sugerman
Elevated intra-abdominal pressure increases plasma renin activity and aldosterone levels.
The Journal of trauma 1997;42(6):997-1004; discussion 1004-5.
1997: Don Farthing; Kim L R Brouwer; Itaf Fakhry; Domenic A Sica
Solid-phase extraction and determination of ranitidine in human plasma by a high-performance liquid chromatographic method utilizing midbore chromatography.
Journal of chromatography. B, Biomedical sciences and applications 1997;688(2):350-3.
1997: Todd W B Gehr; Domenic A Sica; PH Slugg; Janis L Hammett; R Raymond; Neville F Ford
The pharmacokinetics of pravastatin in patients on chronic hemodialysis.
European journal of clinical pharmacology 1997;53(2):117-21.
1997: Don Farthing; Lynne Gehr; B Berger; Itaf Fakhry; Domenic A Sica
Simple method for simultaneous determination of halothane, enflurane, and isoflurane in Krebs solution using capillary gas chromatography.
Biomedical chromatography : BMC 1997;11(1):29-32.
1996: Dawn K Wilson; L Bayer; Domenic A Sica
Variability in salt sensitivity classifications in black male versus female adolescents.
Hypertension 1996;28(2):250-5.
1996: Domenic A Sica; Todd W B Gehr
Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships.
Clinical pharmacokinetics 1996;30(3):229-49.
1996: J Shi; E Ripley; Todd W B Gehr; Domenic A Sica; K A Dandekar; P H Hinderling
Pharmacokinetics of sematilide in renal failure.
Journal of clinical pharmacology 1996;36(2):131-43.
1995: Domenic A Sica; M W Lo; W C Shaw; W F Keane; Todd W B Gehr; C E Halstenson; K Lipschutz; C I Furtek; M A Ritter; S Shahinfar
The pharmacokinetics of losartan in renal insufficiency.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1995;13(1):S49-52.
1994: Don Farthing; Domenic A Sica; Itaf Fakhry; D L Walters; E A Cefali; G Allan
Determination of flutamide and hydroxyflutamide in dog plasma by a sensitive high performance liquid chromatography method utilizing mid-bore chromatography.
Biomedical chromatography : BMC 1994;8(5):251-4.
1994: Robert A Blum; T J Comstock; Domenic A Sica; R W Schultz; E Keller; P Reetze; HN Bockbrader; D Tuerck; J A Busch; P A Reece
Pharmacokinetics of gabapentin in subjects with various degrees of renal function.
Clinical pharmacology and therapeutics 1994;56(2):154-9.
1994: DW Rudy; Todd W B Gehr; G R Matzke; W G Kramer; Domenic A Sica; D Craig Brater
The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency.
Clinical pharmacology and therapeutics 1994;56(1):39-47.
1994: Todd W B Gehr; DW Rudy; G R Matzke; W G Kramer; Domenic A Sica; D Craig Brater
The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency.
Clinical pharmacology and therapeutics 1994;56(1):31-8.
1994: Don Farthing; Domenic A Sica; Itaf Fakhry; Todd W B Gehr
Novel high-performance liquid chromatographic method using solid-phase on-line elution for determination of metolazone in plasma and whole blood.
Journal of chromatography. B, Biomedical applications 1994;653(2):171-6.
1994: E B Ripley; Todd W B Gehr; H Wallace; J Wade; C Kish; Domenic A Sica
The effect of nonsteroidal agents (NSAIDs) on the pharmacokinetics and pharmacodynamics of metolazone.
International journal of clinical pharmacology and therapeutics 1994;32(1):12-8.
1994: E B Ripley; Todd W B Gehr; C W Kish; Domenic A Sica
Hormonal, blood pressure, and peritoneal transport response to short-term ACE inhibition.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1994;14(4):378-83.
1993: T Fullerton; Domenic A Sica; Robert A Blum
Evaluation of the renal protective effect of misoprostol in elderly, osteoarthritic patients at risk for nonsteroidal anti-inflammatory drug-induced renal dysfunction.
Journal of clinical pharmacology 1993;33(12):1225-32.
1993: Domenic A Sica; M Midha; G Aronoff; G Bergen
Atrial natriuretic factor in spinal cord injury.
Archives of physical medicine and rehabilitation 1993;74(9):969-72.
1993: D Craig Brater; D R Rudy; J R Voelker; P K Greene; Todd W B Gehr; Domenic A Sica
Pharmacokinetics and pharmacodynamics of torasemide in patients with chronic renal insufficiency--preliminary evaluation.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1993;7 Suppl 1():69-73.
1993: Todd W B Gehr; Domenic A Sica; D M Grasela; K L Duchin
The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients.
European journal of clinical pharmacology 1993;45(5):431-6.
1992: Don Farthing; T Karnes; Todd W B Gehr; C March; Itaf Fakhry; Domenic A Sica
External-standard high-performance liquid chromatographic method for quantitative determination of furosemide in plasma by using solid-phase extraction and on-line elution.
Journal of pharmaceutical sciences 1992;81(6):569-71.
1992: Domenic A Sica
Kinetics of angiotensin-converting enzyme inhibitors in renal failure.
Journal of cardiovascular pharmacology 1992;20 Suppl 10():S13-20.
1991: DW Rudy; Domenic A Sica; T Comstock; J Davis; J Savory; A C Schoolwerth
Aluminum-citrate interaction in end-stage renal disease.
The International journal of artificial organs 1991;14(10):625-9.
1991: E A Cefali; W J Poynor; Domenic A Sica; S Cox
Pharmacokinetic comparison of flurbiprofen in end-stage renal disease subjects and subjects with normal renal function.
Journal of clinical pharmacology 1991;31(9):808-14.
1991: Domenic A Sica; R E Cutler; R J Parmer; N F Ford
Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.
Clinical pharmacokinetics 1991;20(5):420-7.
1991: Todd W B Gehr; Domenic A Sica; D C Brater; H J Wallace; J Davis; Itaf Fakhry
Metolazone pharmacokinetics and pharmacodynamics in renal transplantation.
International journal of clinical pharmacology, therapy, and toxicology 1991;29(3):116-23.
1991: J R Nunley; A King; T Comstock; M Posner; C Marshall; Domenic A Sica
Cyclosporine's effect on functional reserve in the renal allograft.
Transplantation 1991;51(1):190-3.
1991: Todd W B Gehr; Domenic A Sica; D M Grasela; Itaf Fakhry; J Davis; K L Duchin
Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients.
European journal of clinical pharmacology 1991;41(2):165-9.
1990: Don Farthing; Itaf Fakhry; Todd W B Gehr; Domenic A Sica
Quantitation of metolazone in urine by high-performance liquid chromatography with fluorescence detection.
Journal of chromatography 1990;534():228-32.
1990: Domenic A Sica; M Midha; E Zawada; W Stacy; R Hussey
Hyponatremia in spinal cord injury.
The Journal of the American Paraplegia Society 1990;13(4):78-83.
1990: R Ellenberg; A L King; Domenic A Sica; M Posner; J Savory
Cerebrospinal fluid aluminum levels following deferoxamine.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1990;16(2):157-9.
1990: Domenic A Sica; T J Comstock; J Davis; L Manning; R Powell; A Melikian; G Wright
Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals.
European journal of clinical pharmacology 1990;39(2):193-4.
1990: J R Nunley; Domenic A Sica; V Smith
Medullary sponge kidney and staghorn calculi.
Urologia internationalis 1990;45(2):118-21.
1989: Domenic A Sica; R M Culpepper
Severe hyponatremia in spinal cord injury.
The American journal of the medical sciences 1989;298(5):331-3.
1989: Domenic A Sica; T J Comstock
Pseudoephedrine accumulation in renal failure.
The American journal of the medical sciences 1989;298(4):261-3.
1989: Domenic A Sica; Todd W B Gehr
Diuretics in congestive heart failure.
Cardiology clinics 1989;7(1):87-97.
1989: T J Comstock; Domenic A Sica; A Harford; F Eshelman
Ranitidine bioavailability and disposition kinetics in patients undergoing chronic hemodialysis.
Nephron 1989;52(1):15-9.
1989: Domenic A Sica; Todd W B Gehr
Triamterene and the kidney.
Nephron 1989;51(4):454-61.
1988: T J Comstock; Domenic A Sica; S Stone; J Davis; William R Garnett; H Thomas Karnes; C W Warner
Ranitidine accumulation in patients undergoing chronic hemodialysis.
Journal of clinical pharmacology 1988;28(12):1081-5.
1988: A I Wolfert; Domenic A Sica
Narcotic usage in renal failure.
The International journal of artificial organs 1988;11(6):411-5.
1988: Todd W B Gehr; Domenic A Sica; C Brater; J Davis; Itaf Fakhry
Furosemide pharmacokinetics and pharmacodynamics in renal transplantation.
Clinical pharmacology and therapeutics 1988;43(5):547-53.
1988: Domenic A Sica; C Yonce; R Small; E Cefali; A Harford; W Poynor
Pharmacokinetics of procainamide in continuous ambulatory peritoneal dialysis.
International journal of clinical pharmacology, therapy, and toxicology 1988;26(2):59-64.
1987: Todd W B Gehr; Domenic A Sica
Case report and review of the literature: ureteral endometriosis.
The American journal of the medical sciences 1987;294(5):346-52.
1987: J R Voelker; D Cartwright-Brown; S Anderson; J Leinfelder; Domenic A Sica; J P Kokko; D Craig Brater
Comparison of loop diuretics in patients with chronic renal insufficiency.
Kidney international 1987;32(4):572-8.
1987: Domenic A Sica; T Comstock; A Harford; F Eshelman
Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis.
European journal of clinical pharmacology 1987;32(6):587-91.
1986: B Smith; Domenic A Sica; W Stacy
Peritoneal dialysis in spinal cord injury.
Nephron 1986;44(3):245-8.
1986: A M Harford; Domenic A Sica; T Tartaglione; R E Polk; H P Dalton; W Poynor
Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
Nephron 1986;43(3):217-22.
1985: M S Dawson; A M Harford; B K Garner; Domenic A Sica; D M Landwehr; H P Dalton
Total volume culture technique for the isolation of microorganisms from continuous ambulatory peritoneal dialysis patients with peritonitis.
Journal of clinical microbiology 1985;22(3):391-4.
1984: Domenic A Sica; M Midha; E T Zawada; M Johnson; R W Hussey; W K Stacy
Prostaglandin E2 excretion in spinal cord injury patients.
The Journal of the American Paraplegia Society 1984;7(2):27-30.